Literature DB >> 24493974

Formulation and optimization of orodispersible tablets of flutamide.

Kadria A Elkhodairy1, Maha A Hassan2, Samar A Afifi3.   

Abstract

The present study aimed to formulate orodispersible tablets of flutamide (FTM) to increase its bioavailability. Orodispersible tablets were prepared by direct compression technique using three different approaches namely; super-disintegration, effervescence and sublimation. Different combined approaches were proposed and evaluated to optimize tablet characteristics. Sodium starch glycolate (SSG) was used as the superdisintegrant. The prepared powder mixtures were subjected to both pre and post compression evaluation parameters including; IR spectroscopy, micromeritics properties, tablet hardness, friability, wetting time, disintegration time and in-vitro drug release. IR studies indicated that there was no interaction between the drug and the excipients used except Ludipress. The results of micromeritics studies revealed that all formulations were of acceptable to good flowability. Tablet hardness and friability indicated good mechanical strength. Wetting and dispersion times decreased from 46 to 38 s by increasing the SSG concentration from 3.33 to 6.66% w/w in tablets prepared by superdisintegration method. The F8 formulation which was prepared by combined approaches of effervescence and superdisintegrant addition gave promising results for tablet disintegration and wetting times but failed to give faster dissolution rate. The incorporation of 1:5 solid dispersion of FTM: PEG 6000 instead of the pure drug in the same formulation increased the drug release rate from 73.12 to 96.99% after 15 min. This increase in the dissolution rate may be due to the amorphization of the drug during the solid dispersion preparation. The presence of the amorphous form of the drug was shown in the IR spectra.

Entities:  

Keywords:  Effervescence; Flutamide; Orodispersible tablets; Sublimation; Superdisintegrant-addition

Year:  2013        PMID: 24493974      PMCID: PMC3909754          DOI: 10.1016/j.jsps.2013.01.009

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  3 in total

1.  The concept of dissolution efficiency.

Authors:  K A Khan
Journal:  J Pharm Pharmacol       Date:  1975-01       Impact factor: 3.765

2.  Flutamide-hydroxypropy-beta-chiyclodextrin complex: formulation, physical characterization, and absorption studies using the Caco-2 in vitro model.

Authors:  Z Zuo; G Kwon; B Stevenson; J Diakur; L I Wiebe
Journal:  J Pharm Pharm Sci       Date:  2000 May-Aug       Impact factor: 2.327

3.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.

Authors:  Mukesh Gohel; Madhabhai Patel; Avani Amin; Ruchi Agrawal; Rikita Dave; Nehal Bariya
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

  3 in total
  7 in total

Review 1.  Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.

Authors:  Mohammadali Poursharifi Ghourichay; Seyed Hossein Kiaie; Ali Nokhodchi; Yousef Javadzadeh
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

2.  Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design.

Authors:  Robert-Alexandru Vlad; Paula Antonoaea; Nicoleta Todoran; Emöke-Margit Rédai; Magdalena Bîrsan; Daniela-Lucia Muntean; Silvia Imre; Gabriel Hancu; Lénárd Farczádi; Adriana Ciurba
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

3.  Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Mohamed S Mohamed; Reda A Mahmoud; Ahmed A El-Shenawy; Essam A Mahmoud; Ahmed A Al-Karmalawy; Eman Y Santali; Sameer Alshehri; Mahmoud Elkot Mostafa Elsadek; Mohamed A El Hamd; Abd El Hakim Ramadan
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

4.  Design and In Vitro Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium.

Authors:  Amjad Hussain; Maham Misbah; Nasir Abbas; Muhammad Irfan; Muhammad Sohail Arshad; Rahat Shamim; Nadeem Irfan Bukhari; Faisal Mahmood
Journal:  Turk J Pharm Sci       Date:  2020-10-30

5.  Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique.

Authors:  Amer S AlAli; Mohammed F Aldawsari; Ahmed Alalaiwe; Bjad K Almutairy; Ramadan Al-Shdefat; Ismail A Walbi; Mohamed H Fayed
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

6.  Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.

Authors:  Yi-Dan Chen; Zhong-Yuan Liang; Yan-Yan Cen; He Zhang; Mei-Gui Han; Yun-Qiao Tian; Jie Zhang; Shu-Jun Li; Da-Sheng Yang
Journal:  Drug Des Devel Ther       Date:  2015-11-20       Impact factor: 4.162

7.  Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients.

Authors:  Manpreet Kaur; Amit Mittal; Monica Gulati; Deepika Sharma; Rajesh Kumar
Journal:  Recent Pat Drug Deliv Formul       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.